Global Chicken Marek's Disease Live Vaccine Market Growth 2024-2030

Marek’s disease (MD) is a chronic infectious disease in chickens caused by alphaherpesvirus. Marek's disease poses a huge threat to the world's poultry industry. Chickens infected with Marek's disease virus (MDV) can develop lymphoma, short-term paralysis, atherosclerosis, permanent nervous system damage, and death; mild infections can also cause laying hens to lay eggs. Production traits such as yield and egg weight decreased significantly.

The global Chicken Marek's Disease Live Vaccine market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime, Inc. (LPI) ' newest research report, the “Chicken Marek's Disease Live Vaccine Industry Forecast” looks at past sales and reviews total world Chicken Marek's Disease Live Vaccine sales in 2023, providing a comprehensive analysis by region and market sector of projected Chicken Marek's Disease Live Vaccine sales for 2024 through 2030. With Chicken Marek's Disease Live Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chicken Marek's Disease Live Vaccine industry.

This Insight Report provides a comprehensive analysis of the global Chicken Marek's Disease Live Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chicken Marek's Disease Live Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chicken Marek's Disease Live Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chicken Marek's Disease Live Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chicken Marek's Disease Live Vaccine.

United States market for Chicken Marek's Disease Live Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Chicken Marek's Disease Live Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Chicken Marek's Disease Live Vaccine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Chicken Marek's Disease Live Vaccine players cover:

• Harbin Weike Biotechnology
• Harbin Guosheng Biotechnology
• Fujian Shengwei Biotechnology
• Liaoning Yikang Biology
• Boehringer Ingelheim Animal Health

This report presents a comprehensive overview, market shares, and growth opportunities of Chicken Marek's Disease Live Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type:

• Chicken Marek's Disease Live Vaccine
• Chicken Marek's Disease Bivalent Live Vaccine

Segmentation by application:

• Government Tender
• Marketing

This report also splits the market by region:

• Americas
  • United States
  • Canada
  • Mexico
  • Brazil
• APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
• Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Harbin Weike Biotechnology
• Harbin Guosheng Biotechnology
• Fujian Shengwei Biotechnology
• Liaoning Yikang Biology
• Boehringer Ingelheim Animal Health
• MSD Animal Health
• Ceva
• Zoetis
• Dahuanong
• Ruipu Biotechnology
• Sinopharm Animal Health
• Harbin Pharmaceutical Group Biological Vaccine

Key Questions Addressed in this Report

• What is the 10-year outlook for the global Chicken Marek's Disease Live Vaccine market?
• What factors are driving Chicken Marek's Disease Live Vaccine market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Chicken Marek's Disease Live Vaccine market opportunities vary by end market size?
• How does Chicken Marek's Disease Live Vaccine break out type, application?